Evidence map›Paper›PMID 21322093›Full record

ArticleJournal of mass spectrometry : JMS2011

The evolving field of imaging mass spectrometry and its impact on future biological research.

Jeramie D Watrous, Theodore Alexandrov, Pieter C Dorrestein

Abstract read
In one paragraph

Article in Journal of mass spectrometry : JMS, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Article
  2. Article
  3. Mass Spectrometry-Based Tissue Imaging of Small Molecules.Advances in experimental medicine and biology · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Biocontrol of Cereal Crop Diseases Using Streptomycetes.Pathogens (Basel, Switzerland) · 2019
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jeramie D WatrousDepartment of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
Theodore Alexandrov
Pieter C Dorrestein

Funding

MOLECULAR BIOPHYSICS TRAINING PROGRAMT32GM008326 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KOMIVES, ELIZABETH A. · 1989 to 2020
$7.5M
Real-Time Imaging of metabolic CommunicationR01GM094802 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DORRESTEIN, PIETER C · 2010 to 2013
$1.0M
New approaches to sequencing of complex peptides.R01GM086283 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DORRESTEIN, PIETER C, PEVZNER, PAVEL A · 2008 to 2010
$984k
NIGMS NIH HHS GM08326NIGMS NIH HHS GM086283NIGMS NIH HHS GM094802NIGMS NIH HHS R01 GM086283NIGMS NIH HHS R01 GM094802NIGMS NIH HHS T32 GM008326
6 · The paper itself

Abstract

Within the past decade, imaging mass spectrometry (IMS) has been increasingly recognized as an indispensable technique for studying biological systems. Its rapid evolution has resulted in an impressive array of instrument variations and sample applications, yet the tools and data are largely confined to specialists. It is therefore important that at this junction the IMS community begin to establish IMS as a permanent fixture in life science research thereby making the technology and/or the data approachable by non-mass spectrometrists, leading to further integration into biological and clinical research. In this perspective article, we provide insight into the evolution and current state of IMS and propose some of the directions that IMS could develop in order to stay on course to become one of the most promising new tools in life science research.

Indexed as

AnimalsBacteriological TechniquesBiomedical ResearchHumansMass SpectrometryMedical InformaticsMiceMolecular ImagingRats

Identifiers

PMID21322093
PMCPMC3303182

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.